FREQUENCY OF AND TESTING PATTERNS FOR MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS IN A US COMMUNITY ONCOLOGY SETTING

被引：0
|
作者：
Chase, M. [1 ]
Vasudevan, A. [2 ]
Amonkar, M.
Myer, N. [1 ]
Wang, T. [1 ]
Prabhu, V [3 ]
Turzhitsky, V [1 ]
Spira, A. [4 ]
机构：
[1] Merck Co Inc, Kenilworth, NJ USA
[2] Ontada, The Woodlands, TX USA
[3] Merck Co Inc, North Wales, PA USA
[4] US Oncol Res Virginia Canc Specialists, Faifax, VA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH95
引用
收藏
页码：S452 / S452
页数：1
相关论文
共 50 条
  • [1] STRUCTURED LITERATURE REVIEW OF THE PREVALENCE OF MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS
    Lorenzi, M.
    Amonkar, M.
    Zhang, J.
    Mehta, S.
    Liaw, K.
    [J]. VALUE IN HEALTH, 2018, 21 : S22 - S23
  • [2] Epidemiology of Microsatellite Instability High (MSI-H) and Deficient Mismatch Repair (dMMR) in Solid Tumors: A Structured Literature Review
    Lorenzi, Maria
    Amonkar, Mayur
    Zhang, Jacky
    Mehta, Shivani
    Liaw, Kai-Li
    [J]. JOURNAL OF ONCOLOGY, 2020, 2020
  • [3] Pembrolizumab in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors: An update of the phase II KEYNOTE-158 trial
    Maio, M.
    Ascierto, P. A.
    Motola Kuba, D.
    Penel, N.
    Cassier, P. A.
    Bariani, G. M.
    De Jesus-Acosta, A.
    Doi, T.
    Longo Munoz, F.
    Miller, W. H.
    Oh, D-Y.
    Gottfried, M.
    Yao, L.
    Jin, F. J.
    Gozman, A.
    Marabelle, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S589 - S590
  • [4] SYSTEMATIC AND STRUCTURED REVIEWS OF THE DISEASE BURDEN IN PATIENTS WITH MICROSATELLITE INSTABILITY HIGH (MSI-H) OR MISMATCH REPAIR DEFICIENT (DMMR) COLORECTAL CANCER (CRC)
    Amonkar, M.
    Chase, M.
    Takyar, J.
    Sharma, S.
    [J]. VALUE IN HEALTH, 2021, 24 : S24 - S24
  • [5] Clinicopathological and genomic characteristics of DNA Mismatch Repair-Deficient (dMMR) and microsatellite instability-high (MSI-H) resected gastric adenocarcinoma
    Zhou, J.
    Liang, B.
    Yin, M.
    Zhang, H.
    Liu, F.
    Dong, L.
    Zhang, B.
    Xu, Y.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S921 - S922
  • [6] Neoadjuvant nivolumab plus ipilimumab in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) rectal tumors: ECOG-ACRIN EA2201
    Ciombor, K. K.
    Hong, S.
    Eng, C.
    Yao, X.
    You, N.
    Das, P.
    Chakravarthy, A.
    O'Dwyer, P. J.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S104 - S104
  • [7] The efficacy of pembrolizumab in patients with high-frequency microsatellite instability (MSI-H) solid tumors
    Sugimoto, Naotoshi
    Hasegawa, Akiko
    Takada, Ryoji
    Abe, Yutaro
    Kai, Yugo
    Fukutake, Nobuyasu
    Ikezawa, Kenji
    Yamamoto, Sachiko
    Watanabe, Masahiro
    Hisa, Tsuyoshi
    Oota, Yukinobu
    Kuno, Ikumi
    Otsuka, Tomoyuki
    Nishio, Minako
    Kudo, Toshihiro
    Fujisawa, Fumie
    Yagi, Toshinari
    Ohkawa, Kazuyoshi
    Kamiura, Shoji
    Imamura, Fumio
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S302 - S302
  • [8] The clinical courses of solid tumors with microsatellite instability-high (MSI-H)
    Inagaki, Yuichiro
    Ohara, Fumiya
    Yokota, Hirofumi
    Takeuchi, Yuki
    Sawa, Hitomi
    Miyao, Kotaro
    Takashi, Seki
    Arima, Junko
    Yoneyama, Eiji
    Sawa, Masashi
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S344 - S344
  • [9] A single-arm, phase II, multicenter study of iparomlimab (QL1604) in patients (pts) with unresectable/metastatic deficient mismatch repair (dMMR)/microsatellite instability high (MSI-H) solid tumors
    Guo, W.
    Bi, F.
    Dong, J.
    Jin, C.
    Niu, Z.
    Wang, Y.
    Sun, M.
    Wang, T.
    Yu, D.
    He, Y.
    Zhang, R.
    Yin, X.
    Feng, W.
    Zhang, M.
    Li, L.
    Zhang, B.
    Kang, X.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1511 - S1511
  • [10] Pembrolizumab in microsatellite instability high (MSI-H)/ mismatch repair deficient (dMMR) cancers: Updated analysis from phase 2 KEYNOTE-158 study.
    Maio, Michele
    Ascierto, Paolo Antonio
    Manzyuk, Ludmila
    Motola-Kuba, Daniel
    Penel, Nicolas
    Cassier, Philippe A.
    Bariani, Giovanni
    De Jesus-Acosta, Ana
    Doi, Toshihiko
    Longo, Federico
    Miller, Wilson H.
    Oh, Do-Youn
    Gottfried, Maya
    Wang, Ruixue
    Jin, Fan
    Norwood, Kevin Glen
    Marabelle, Aurelien
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345